Where Clinical Data, Science & Evidence Transforms Women’s Health
David Friend
Chief Science Officer Daré Bioscience
Day One - Thursday, December 3, 2026
11:00 AM Explore Innovative Product Manufacturing Pathways Beyond Conventional Regulatory Models
- Highlight how women’s health innovators can move beyond conventional FDA approval by leveraging compounding pathways enabling faster patient access to needed therapies while still meeting defined quality and safety requirements
- Address the core challenge of patient skepticism around compounded therapies by embedding strong scientific validation, transparent sourcing, robust GMP manufacturing controls, and consistent quality guarantees
